Farrokhlagha Ahmadi
1*1 Division of Nephrology, Nephrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Implication for health policy/practice/research/medical education
A high level of fibroblast growth factor-23 (FGF-23) is the initial abnormality of mineral metabolism in chronic kidney disease (CKD). Results of several studies indicate a relation between FGF23 and LVH. Cardiovascular disease is an important cause of death in patients with CKD and elevated FGF-23 is a strong predictor of mortality. Additionally, FGF23 was independently connected to an increased risk for cardiovascular mortality in individuals with renal failure with manifest coronary artery disease.
Please cite this paper as: Ahmadi F. FGF 23 and cardiovascular outcome in chronic kidney disease. J Parathyr Dis. 2016;4(2):34-35.